Transaction · 0001214659-26-010645

Finn Patrick John

Finn Patrick John, PRES, reported a transaction classified as exercise at Twist Bioscience Corp involving 23355.000000 shares for an estimated $1584636.75. Reported holdings after the transaction were 293033.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MPRES
TWSTTwist Bioscience Corp
Filing timeAug 20
Trade dateAug 18, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$136.22
Pre-filing
1mo ago -31.1%1w ago -9.6%1d ago -8.7%
Returns since
7d +12.4%30d -3.1%90d -3.1%180d -3.1%1y -3.1%

TWST price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TWST since 2026-08-20Filed 15 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001214659-26-010645
Common Stock
Transaction date
Aug 18, 2026
Filed Aug 20, 2026, 08:05 PM · 2d delay
Shares
23.3k sh
$6.78k per share
Estimated value
$158M
Computed from shares × price
Holdings after
293k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026.

  2. F2

    Represents the weighted average sales price per share. The shares sold at prices ranging from $115.35 to $116.33 per share. Full information regarding the number of shares sold at each price shall be…

  3. F3

    Represents the weighted average sales price per share. The shares sold at prices ranging from $116.37 to $117.36 per share. Full information regarding the number of shares sold at each price shall be…

  4. F4

    Represents the weighted average sales price per share. The shares sold at prices ranging from $117.37to $118.19 per share. Full information regarding the number of shares sold at each price shall be p…

  5. F5

    Represents the weighted average sales price per share. The shares sold at prices ranging from $118.505 to $119.45 per share. Full information regarding the number of shares sold at each price shall be…

  6. F6

    Represents the weighted average sales price per share. The shares sold at prices ranging from $119.515 to $120.2 per share. Full information regarding the number of shares sold at each price shall be…

  7. F7

    Represents the weighted average sales price per share. The shares sold at prices ranging from $120.585 to $121.53 per share. Full information regarding the number of shares sold at each price shall be…

  8. F8

    Represents the weighted average sales price per share. The shares sold at prices ranging from $122.00 to $122.815 per share. Full information regarding the number of shares sold at each price shall be…

  9. F9

    The option was 100% exercisable on December 19, 2022.

Original filing · 0001214659-26-010645
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TWST